MLKL and metabolic dysfunction-associated steatohepatitis: Both the regulatory factor RIP3 and the execution factor MLKL of necroptosis are expressed at low levels in the normal liver [93], NASH patients and dietary NASH mouse models demonstrated increased expression of RIP3 in the liver and elevated levels of RIP1 and MLKL in the serum [94, 95].